Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing 

Slides:



Advertisements
Similar presentations
Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.
Advertisements

Abnormal epicardial electrophysiologic substrate in patients with early repolarization pattern and reduced left ventricular systolic function: A report.
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.
Pulmonary arterial pressure sensing in a patient with left ventricular assist device during ventricular arrhythmia  Jill R. Harris, MSN, ACNP-C, CNS,
Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.
Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device  Michele Murphy, MD, Timothy.
Erroneous shock by an AED: Importance of obtaining AED tracing to prevent inappropriate ICD implantation  Brian J. Cross, MD, Mark S. Link, MD, FHRS 
Federico Migliore et al. JACEP 2016;2:
Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference  John Wight, BS,
Inappropriate shock from delayed T-wave oversensing by a subcutaneous implantable cardioverter-defibrillator after septal myectomy for hypertrophic cardiomyopathy 
Recurrent commotio cordis: Déjà vu
A case of paroxysmal atrioventricular block–induced cardiac arrest
Prakash G. Suryanarayana, MD, David S. Frankel, MD, FHRS, Francis E
Combination of a leadless pacemaker and subcutaneous defibrillator: First in-human report  Blandine Mondésert, MD, Marc Dubuc, MD, FHRS, Paul Khairy,
Breast tissue expanders and implantable cardioverter-defibrillator: An unusual interaction  Malik Muhammad Khurram Sher Khan, MD, Malik Muhammad Humayun.
Unusual case of late dislodgment of a superior vena cava coil
Is it bradycardia or something else causing symptoms?
T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome 
Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child  Carlo de Asmundis, MD, PhD,
Inappropriate defibrillator shock during gynecologic electrosurgery
Anne Barnett, PA-C, Lee Eckhardt, MD, FHRS, Miguel A. Leal, MD, FHRS 
Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,
Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome  Akira Miyake, MD, Heima.
Recurrent idiopathic polymorphic ventricular tachycardia/ventricular fibrillation successfully treated by cardiac sympathetic denervation  Faisal Matto,
Increased threshold in nonselective His-bundle pacing suspected to be caused by amiodarone  JoonHyuk Kim, MD, Seth Goldbarg, MD, FHRS, Steven Leung, MD,
T-wave oversensing from postural changes: A rare cause of inappropriate shock from a subcutaneous defibrillator  Muhammad R. Afzal, MD, Auroa Badin, MD,
Failure of ICD therapy in lethal arrhythmogenic right ventricular cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu mutation  Kasper Aalbæk Kjærgaard,
Substernal implantation of a subcutaneous implantable cardioverter-defibrillator in a patient with preexisting Hemodialysis Reliable Outflow graft  Thomas.
Pulmonary arterial pressure sensing in a patient with left ventricular assist device during ventricular arrhythmia  Jill R. Harris, MSN, ACNP-C, CNS,
Elisa Ebrille, MD, Fernando M. Contreras-Valdes, MD, Peter J
Oral quinine sulfate for the treatment of electrical storm and prevention of recurrent shocks in Brugada syndrome after failed cilostazol therapy  Jayaprakash.
Cardiac contractility modulation therapy: Are there superresponders?
Repeat inappropriate defibrillator discharges following defibrillator implantation. What is the mechanism and treatment?  Jeremy W. Docekal, MD, Mark.
Intravenous sotalol for conversion of atrial flutter in infants
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator  Mohammad-Ali.
Right-sided subcutaneous implantable cardioverter-defibrillator placement in a patient with dextrocardia, tetralogy of Fallot, and conduction disease 
Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system  Konstantinos Kossidas,
Inappropriate shocks in a patient with a subcutaneous implantable cardioverter- defibrillator  Sana M. Al-Khatib, MD, MHS, FHRS, Sasmrita Belbase, NP,
Transvenous approach to pacemaker lead implantation for sinus node dysfunction after extracardiac lateral tunnel Fontan conduit placement  Edward O’Leary,
Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death  Johnni Rudbeck-Resdal, MD, Jens.
Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator  Sing-Chien Yap, MD, PhD, Rohit E. Bhagwandien,
Oversensing of an unexpected atrial flutter
Inappropriate subcutaneous implantable cardioverter-defibrillator therapy due to R-wave amplitude variation: Another challenge in device management  Syeda.
Daniel W. Nelson, BS, Caroline Vloka, BA, Jule Wetherbee, MD 
Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular.
Undetected ventricular fibrillation in a single-chamber implantable cardioverter- defibrillator: When the far-field channel sees more than the intraventricular.
Successful implantation of a subcutaneous cardiac defibrillator in a patient with a preexisting deep brain stimulator  Yousef Bader, MD, Jonathan Weinstock,
Elizabeth V. Saarel, MD, FHRS, Susan P. Etheridge, MD, FHRS, David G
Unstable accelerated idioventricular rhythm in a neonate with congenital heart disease  Jonathon Hagel, BMSc, MB, BCH, BAO, Carolina Escudero, BSc, MSc,
Changing place, changing future: Repositioning a subcutaneous implantable cardioverter-defibrillator can resolve inappropriate shocks secondary to myopotential.
Subcutaneous implantable cardioverter-defibrillator implantation in a patient with bilateral pectoral deep brain stimulators  Thor Tejada, MD, Faisal.
Different rate-dependent responses between J waves and the notches on an epicardial local electrogram in a patient with idiopathic ventricular fibrillation 
Abnormal epicardial electrophysiologic substrate in patients with early repolarization pattern and reduced left ventricular systolic function: A report.
Impact of a novel algorithm designed to reduce T-wave oversensing with the subcutaneous defibrillator in a patient with type I Brugada electrocardiogram 
Abdominal implantable cardioverter-defibrillator placement in a patient requiring bilateral chest radiation therapy  Ankur A. Karnik, MD, FHRS, CCDS,
Serious case of the hiccups
Colin Yeo, MBBS, Martin Green, MD, Robert Lemery, MD, FHRS 
The runaway defibrillator…A case of an implantable cardioverter-defibrillator that failed communication and deactivation with a magnet  Mahmoud Assaad,
Intermittent failure to capture: What is the mechanism?
Right ventricularly paced right bundle–type pattern on ECG: Does this preclude upgrading to biventricular pacing?  Adrian H. Shandling, MD, FACC, Gregory.
Peter Kabunga, MBChB, MRCP, George J. Klein, MD, FHRS, Raymond W
Nothing inside the heart – Combining epicardial pacing with the S-ICD
Implantation of the subcutaneous implantable cardioverter-defibrillator with retroperitoneal generator placement in a child with hypoplastic left heart.
Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T- wave oversensing in hyperkalemia leading to ventricular fibrillation 
Cardiac implantable electronic device malfunction after deceleration injury without obvious chest trauma  Amr F. Barakat, MD, Brian Cross, MD, Jonathan.
Mobile subcutaneous implantable cardioverter-defibrillator leads to oversensing and inappropriate shocks  Omid Kiamanesh, MD, Jacob M. Larsen, MD, PhD,
Resolution of new left bundle branch block and ventricular tachycardia with immunosuppressive therapy in a patient with cardiac sarcoidosis  Aatish Garg,
Orthostatic increase in defibrillation threshold leading to defibrillation failure and prolonged cardiac arrest in a sitting position: Lessons from a.
T-wave oversensing during left ventricular pacing causing inappropriate defibrillation  Joshua Payne, MD, MPH, Sandeep Gautam, MD, MPH, FHRS, Richard Weachter,
Substernal subcutaneous implantable cardioverter-defibrillator lead placement for the management of inappropriate shocks  Khuyen Do, MD, Chin C. Lee,
Presentation transcript:

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing  Ali A. Sovari, MD, Ashkan Ehdaie, MD, Qiang Liu, MS, Xunzhang Wang, MD, Charles Swerdlow, MD, FHRS, Michael Shehata, MD, FHRS  HeartRhythm Case Reports  Volume 3, Issue 2, Pages 133-136 (February 2017) DOI: 10.1016/j.hrcr.2016.10.006 Copyright © 2017 Heart Rhythm Society Terms and Conditions

Figure 1 A: Twelve-lead electrocardiogram during sinus rhythm. Screening surface electrograms in lead II (secondary vector) during sinus rhythm at prescreening in B: supine and C: standing positions. HeartRhythm Case Reports 2017 3, 133-136DOI: (10.1016/j.hrcr.2016.10.006) Copyright © 2017 Heart Rhythm Society Terms and Conditions

Figure 2 Twelve-lead electrocardiogram of the ventricular tachycardia (VT) episode. A: The absolute amplitude of the QRS in lead II is 2.3 mV. B: The subcutaneous implantable cardioverter-defibrillator’s stored subcutaneous electrogram of the VT episode in which T- and P-wave oversensing resulted in delivering inappropriate shock. The shock terminates the VT after a few beats and sinus rhythm with similar rate to the VT rate initiates. Note R-wave amplitude is low in VT (0.4–0.8 mV) and much larger in sinus rhythm after the shock (beginning at 61 sec, 2.5–3 mV). HeartRhythm Case Reports 2017 3, 133-136DOI: (10.1016/j.hrcr.2016.10.006) Copyright © 2017 Heart Rhythm Society Terms and Conditions

Figure 3 Posteroanterior (PA) and lateral chest radiographs at presentation with ventricular tachycardia were unchanged compared with radiographs at implantation. HeartRhythm Case Reports 2017 3, 133-136DOI: (10.1016/j.hrcr.2016.10.006) Copyright © 2017 Heart Rhythm Society Terms and Conditions